Hallym University Sacred Heart Hospital

Dr. Lee-Su Kim and his team of the Breast Endocrine Cancer Center at Hallym University Sacred Heart Hospital have recently won a scientific award for their thesis on “GATA-3 as a New Prognostic Marker in Breast Cancer” at the 26th Academic Symposium of the Korean Breast Cancer Society(KBCS).

They succeeded in identifying that breast cancer patients with GATA-3 positive showed more significant improvement in their treatment than those with negative.

GATA-3 is a factor involved in human cell growth and differentiation. It is reported that the factor affects not only normal growth but also tumor development.

“This research is not just a finding of a new prognostic marker in breast cancer, but it could help doctors provide customized treatment to patients according to their characteristics of tumors,” Dr. Kim said.

By Jong Hun Im, Int’l Operations Team, HUMC